Exome Sequencing Opens a New Chapter in CKD
Study results point to a future when whole exome sequencing will be the method of choice for identifying genetic causes of CKD.
Study results point to a future when whole exome sequencing will be the method of choice for identifying genetic causes of CKD.
Although a 2013 guideline recommended statin use to more than 65% of adults with CKD, only about 36% of adults with CKD were taking a statin in 2011-2014.